CA
THC icon

Clearstead Advisors’s Tenet Healthcare THC Stock Holding History

Clearstead Advisors’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32K Sell
171
-977
-85% -$180K ﹤0.01% 1643
2026
Q1 		$217K Sell
1,148
-355
-24% -$74.8K ﹤0.01% 979
2025
Q4 		$299K Buy
1,503
+1,037
+223% +$210K ﹤0.01% 821
2025
Q3 		$94.6K Buy
466
+92
+25% +$16.3K ﹤0.01% 1070
2025
Q2 		$65.8K Buy
374
+99
+36% +$14.9K ﹤0.01% 1195
2025
Q1 		$37K Sell
275
-423
-61% -$55.7K ﹤0.01% 1250
2024
Q4 		$88.1K Hold
698
– – ﹤0.01% 1048
2024
Q3 		$116K Buy
698
+98
+16% +$14.8K ﹤0.01% 995
2024
Q2 		$79.8K Buy
+600
New +$72.2K ﹤0.01% 1051
2022
Q2 		– Sell
-285
Closed -$24K – 1445
2022
Q1 		$24K Buy
+285
New +$23.4K ﹤0.01% 828
2021
Q1 		– Sell
-370
Closed -$15K – 1179
2020
Q4 		$15K Hold
370
– – ﹤0.01% 668
2020
Q3 		$9K Hold
370
– – ﹤0.01% 680
2020
Q2 		$7K Hold
370
– – ﹤0.01% 640
2020
Q1 		$5K Buy
+370
New +$10.6K ﹤0.01% 653

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Clearstead Advisors's THC Position: Q2 2026 in Review

Clearstead Advisors reduced its Tenet Healthcare (THC) stake by 85% in Q2 2026, selling an estimated $180K and leaving 171 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #1643.

Clearstead Advisors first reported a position in THC in Q1 2020 and has held it in 14 quarters since. The position peaked at $299K in Q4 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Clearstead Advisors held 171 shares of Tenet Healthcare worth $32K as of Q2 2026.
  • Clearstead Advisors sold 977 Tenet Healthcare shares in Q2 2026, an estimated $180K.
  • Tenet Healthcare made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1643 holding.
  • Clearstead Advisors first reported a position in Tenet Healthcare in Q1 2020 and has held it in 14 quarters since.
  • Clearstead Advisors's Tenet Healthcare position peaked at $299K in Q4 2025.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.